EJNMMI

European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal that publishes research in the fields of nuclear medicine and molecular imaging. It is published by Springer Nature on behalf of the European Association of Nuclear Medicine (EANM). The journal covers radiochemistry and radiopharmacy, radiopharmaceutical development, imaging instrumentation, and quantitative methods, as well as translational and clinical studies using PET, SPECT, and related modalities.

Subjects include oncologic, neurologic, cardiologic, and other disease areas; preclinical models; dose estimation and dosimetry; image analysis; and advances in imaging-guided therapy. The scope encompasses both basic science and clinical research, aiming to advance diagnostic and therapeutic applications of molecular imaging.

EJNMMI publishes original research articles, review papers, technical notes, and editorials, targeting researchers, clinicians, physicists, radiopharmacists, and technologists involved in nuclear medicine and molecular imaging. The journal seeks to facilitate cross-disciplinary collaboration and the dissemination of methodological advances as well as clinical results that impact patient care.

The publication is associated with the European Association of Nuclear Medicine and is distributed by Springer Nature. It is widely indexed in major bibliographic databases and offers access through traditional subscription models as well as open access options where available.